Vimarsana
Biggest News Aggregation in the World

Page 26 - Offer Share News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Offer Share. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Offer Share Today - Breaking & Trending Today

Investegate |Chariot Oil & Gas Ld Announcements | Chariot Oil & Gas Ld: Posting of Circular and Notice of General Meeting - Vimarsana News

Investegate |Chariot Oil & Gas Ld Announcements | Chariot Oil & Gas Ld: Posting of Circular and Notice of General Meeting

  Chariot (AIM: CHAR), the African focused transitional energy group, is pleased to confirm that, further to the Company's announcement on 25 May 2021, a Circular containing details of the Placing, Subscription and Open Offer, together with the Notice of General Meeting (the "Circular"), has today been posted to Shareholders. A copy of the Circular will be available shortly on the Company's website .   The Company announced on 25 May 2021 that it had conditionally raised gross proceeds of US$16.5 million (£11.7 million) through the successful Placing of and...

Malcy's Blog - Oil price, Chariot, UJO/Reabold, Serica, Hurricane, Touchstone. And finally… - Vimarsana News

Malcy's Blog - Oil price, Chariot, UJO/Reabold, Serica, Hurricane, Touchstone. And finally…

Malcy's Blog - Oil price, Chariot, UJO/Reabold, Serica, Hurricane, Touchstone. And finally… Oil price A rapid about turn from the oil price yesterday, the US seemed to indicate that the Iran deal was ‘not that far down the road yet’ which settled the bulls and also data from them and the UK was more positive. As well as that the US recorded air passenger levels of 2m and reported a big increase in mainly domestic travel although corporate and international numbers were slowly rising. Oil price, Chariot, UJO/Reabold, Serica, Hurricane, Touchstone. And finally… WTI $66.05 +$2.47, Brent ...

Investegate |Accsys Technologies Announcements | Accsys Technologies: Result of Placing - Vimarsana News

Investegate |Accsys Technologies Announcements | Accsys Technologies: Result of Placing

and   Accsys, the fast-growing and eco-friendly company that combines chemistry and technology to create high performance, sustainable wood building products, announces the successful placing of New Ordinary Shares to raise gross proceeds of approximately €33 million. Further to the Company's announcement yesterday afternoon regarding the proposed Placing to be conducted by way of the Bookbuild ("Launch Announcement"), the Company has conditionally placed 20,005,325 New Ordinary Shares at an offer price of €1.65 (£1.40) per share (the "Offer Price"), raising gross Placing proceeds of a...

Announcement of Intention to Float on the Dubai Financial Market - Vimarsana News

Announcement of Intention to Float on the Dubai Financial Market

Announcement of Intention to Float on the Dubai Financial Market DUBAI, UAE, March 23, 2021 /PRNewswire/ -- Tristar Transport (PJSC - under incorporation) ("Tristar" or the "Company" or, with its subsidiaries and subsidiary undertakings, the "Group"), a leading global integrated liquid logistics solutions provider headquartered in Dubai, UAE, today announced its intention to proceed with an initial public offering (the "IPO" or the "Offering") on the Dubai Financial Market ("DFM"). Established in 1998 as a road transport service provider for the petroleum industry in the UAE, Tristar has evo...

Zhaoke Ophthalmology Limited (6622.HK) Announces Proposed Listing on the Main Board of SEHK_Final - Vimarsana News

Zhaoke Ophthalmology Limited (6622.HK) Announces Proposed Listing on the Main Board of SEHK_Final

  Zhaoke Ophthalmology is an ophthalmic pharmaceutical company dedicated to the research, development and commercialization of therapies that address significant unmet medical needs in China. Leveraging its deep domain expertise while designing the pipeline, the Company has initially placed strategic emphasis on five major ophthalmic indications in China in terms of market potential, including dry eye disease, or DED, wet age-related macular degeneration, or wAMD, diabetic macular edema, or DME, myopia and glaucoma. Up to now, the Company has built a comprehensive ophthalmic drug pipeline of...

Source: dgap.de